| Neha Pradip Amin, MD | |
|
500 Upper Chesapeake Dr, Kaufman Cancer Center, Bel Air, MD 21014-4324 | |
| (443) 643-1199 | |
| (443) 643-1198 |
| Full Name | Neha Pradip Amin |
|---|---|
| Gender | Female |
| Speciality | Radiology - Radiation Oncology |
| Location | 500 Upper Chesapeake Dr, Bel Air, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619204534 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0001X | Radiology - Radiation Oncology | D0078864 (Maryland) | Primary |
| Entity Name | University Of Maryland Radiation Oncology Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780637272 PECOS PAC ID: 6406845544 Enrollment ID: O20040512000493 |
News Archive
The Graphene family of materials has emerged as one of the most useful new age nano-biomaterials. Graphene-based materials exhibit excellent physicochemical properties, such as high electrical conductivity, mechanical strength, and high surface area with π-conjugated carbon atoms stacked to form honeycomb structure, suitable for binding other molecules.
BioLight Life Sciences Investments, a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, today announced that it has expanded its relationship with Ora, Inc., a world-leading independent, full-service ophthalmic contract research organization and product development firm, via the signing of a Collaboration Agreement (the "Agreement") pursuant to which the companies will work together to advance the clinical, regulatory and commercial development of BioLight's TeaRx multi-parameter diagnostic test for dry eye syndrome ("DES").
"There is always a risk of suffering injuries during physical activities, and skiing and snowboarding are no exception," said orthotraumatologist Wade Smith, Vice-Chairman of Orthopedics for Geisinger Health System. "Due to the nature of these sports, many of the injuries that skiers and snowboarders suffer are serious and require immediate medical attention."
Despite improved therapy, only one out of every two adult patients survive acute myeloid leukaemia (AML). The mean survival time for this disease, which predominantly occurs in the elderly, is less than a year for patients over 65 years. It is assumed that leukaemic stem cells, which cannot be completely eliminated during treatment, are the origin of relapse.
› Verified 6 days ago
| Entity Name | Sinai Hospital Of Baltimore, Inc |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1124252291 PECOS PAC ID: 0941112346 Enrollment ID: O20091005000646 |
News Archive
The Graphene family of materials has emerged as one of the most useful new age nano-biomaterials. Graphene-based materials exhibit excellent physicochemical properties, such as high electrical conductivity, mechanical strength, and high surface area with π-conjugated carbon atoms stacked to form honeycomb structure, suitable for binding other molecules.
BioLight Life Sciences Investments, a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, today announced that it has expanded its relationship with Ora, Inc., a world-leading independent, full-service ophthalmic contract research organization and product development firm, via the signing of a Collaboration Agreement (the "Agreement") pursuant to which the companies will work together to advance the clinical, regulatory and commercial development of BioLight's TeaRx multi-parameter diagnostic test for dry eye syndrome ("DES").
"There is always a risk of suffering injuries during physical activities, and skiing and snowboarding are no exception," said orthotraumatologist Wade Smith, Vice-Chairman of Orthopedics for Geisinger Health System. "Due to the nature of these sports, many of the injuries that skiers and snowboarders suffer are serious and require immediate medical attention."
Despite improved therapy, only one out of every two adult patients survive acute myeloid leukaemia (AML). The mean survival time for this disease, which predominantly occurs in the elderly, is less than a year for patients over 65 years. It is assumed that leukaemic stem cells, which cannot be completely eliminated during treatment, are the origin of relapse.
› Verified 6 days ago
| Entity Name | Maryland Proton Treatment Center, Llc |
|---|---|
| Entity Type | Part B Supplier - Radiation Therapy Center |
| Entity Identifiers | NPI Number: 1255742375 PECOS PAC ID: 5597070524 Enrollment ID: O20150819008188 |
News Archive
The Graphene family of materials has emerged as one of the most useful new age nano-biomaterials. Graphene-based materials exhibit excellent physicochemical properties, such as high electrical conductivity, mechanical strength, and high surface area with π-conjugated carbon atoms stacked to form honeycomb structure, suitable for binding other molecules.
BioLight Life Sciences Investments, a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, today announced that it has expanded its relationship with Ora, Inc., a world-leading independent, full-service ophthalmic contract research organization and product development firm, via the signing of a Collaboration Agreement (the "Agreement") pursuant to which the companies will work together to advance the clinical, regulatory and commercial development of BioLight's TeaRx multi-parameter diagnostic test for dry eye syndrome ("DES").
"There is always a risk of suffering injuries during physical activities, and skiing and snowboarding are no exception," said orthotraumatologist Wade Smith, Vice-Chairman of Orthopedics for Geisinger Health System. "Due to the nature of these sports, many of the injuries that skiers and snowboarders suffer are serious and require immediate medical attention."
Despite improved therapy, only one out of every two adult patients survive acute myeloid leukaemia (AML). The mean survival time for this disease, which predominantly occurs in the elderly, is less than a year for patients over 65 years. It is assumed that leukaemic stem cells, which cannot be completely eliminated during treatment, are the origin of relapse.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Neha Pradip Amin, MD 500 Upper Chesapeake Dr, Kaufman Cancer Center, Bel Air, MD 21014-4324 Ph: (443) 643-1199 | Neha Pradip Amin, MD 500 Upper Chesapeake Dr, Kaufman Cancer Center, Bel Air, MD 21014-4324 Ph: (443) 643-1199 |
News Archive
The Graphene family of materials has emerged as one of the most useful new age nano-biomaterials. Graphene-based materials exhibit excellent physicochemical properties, such as high electrical conductivity, mechanical strength, and high surface area with π-conjugated carbon atoms stacked to form honeycomb structure, suitable for binding other molecules.
BioLight Life Sciences Investments, a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, today announced that it has expanded its relationship with Ora, Inc., a world-leading independent, full-service ophthalmic contract research organization and product development firm, via the signing of a Collaboration Agreement (the "Agreement") pursuant to which the companies will work together to advance the clinical, regulatory and commercial development of BioLight's TeaRx multi-parameter diagnostic test for dry eye syndrome ("DES").
"There is always a risk of suffering injuries during physical activities, and skiing and snowboarding are no exception," said orthotraumatologist Wade Smith, Vice-Chairman of Orthopedics for Geisinger Health System. "Due to the nature of these sports, many of the injuries that skiers and snowboarders suffer are serious and require immediate medical attention."
Despite improved therapy, only one out of every two adult patients survive acute myeloid leukaemia (AML). The mean survival time for this disease, which predominantly occurs in the elderly, is less than a year for patients over 65 years. It is assumed that leukaemic stem cells, which cannot be completely eliminated during treatment, are the origin of relapse.
› Verified 6 days ago
Randall Joseph Schultz Jr., M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 104 Plumtree Rd Ste 106, Bel Air, MD 21015 Phone: 410-515-4000 | |
Matthew Jeffrey Ferris, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: Kaufman Cancer Center, Department Of Radiation Oncology, 500 Upper Chesapeake Dr., Bel Air, MD 21014 Phone: 443-643-1863 Fax: 443-643-3122 | |
Pablo Luis Gonzalez Lavagnini, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 602 S Atwood Rd, Suite 105, Bel Air, MD 21014 Phone: 410-836-0354 Fax: 410-836-0170 | |
Dr. Kamila Anna Nowak Choi, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 500 Upper Chesapeake Dr, Bel Air, MD 21014 Phone: 443-643-1199 Fax: 443-643-3122 | |
Abimbola Ayoola, M.D Radiology Medicare: Accepting Medicare Assignments Practice Location: 104 Plumtree Rd Ste 106, Bel Air, MD 21015 Phone: 410-515-4000 |